Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.00 +0.22%
Revenue Growth %: +89.5%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +89.5%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.38), $0.85 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- KeyCorp (KEY) files for 158.72M share offering by selling stockholders
- Nakamoto closes healthcare clinics, completes shift to Bitcoin
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
